Publication:
Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose

Issued Date

2013-08-01

Resource Type

Letter

ISSN

10960961
10799796

DOI

10.1016/j.bcmd.2013.03.004

Other identifier(s)

2-s2.0-84878403678

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Blood Cells, Molecules, and Diseases. Vol.51, No.2 (2013), 96-97

Suggested Citation

Bunchoo Pongtanakul, Vip Viprakasit Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose. Blood Cells, Molecules, and Diseases. Vol.51, No.2 (2013), 96-97. doi:10.1016/j.bcmd.2013.03.004 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/31256

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose

Author(s)

Bunchoo Pongtanakul
 Vip Viprakasit

Other Contributor(s)

Mahidol University

Keyword(s)

Biochemistry, Genetics and Molecular Biology
 Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/31256

Collections

Scopus 2011-2015